Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-500
Closed -$379 2207
2023
Q1
$379 Hold
500
﹤0.01% 2264
2022
Q4
$480 Hold
500
﹤0.01% 2216
2022
Q3
$1K Buy
500
+100
+25% +$345 ﹤0.01% 2181
2022
Q2
$1K Hold
400
﹤0.01% 2218
2022
Q1
$2K Sell
400
-660
-62% -$3.34K ﹤0.01% 2041
2021
Q4
$7K Buy
1,060
+193
+22% +$1.32K ﹤0.01% 1467
2021
Q3
$7K Buy
867
+367
+73% +$3.02K ﹤0.01% 1392
2021
Q2
$4K Buy
500
+100
+25% +$698 ﹤0.01% 1648
2021
Q1
$2K Hold
400
﹤0.01% 1922
2020
Q4
$2K Buy
400
+100
+33% +$636 ﹤0.01% 1291
2020
Q3
$2K Buy
+300
New +$2.67K ﹤0.01% 1202

Other funds holding VXRT

TCI Wealth Advisors's VXRT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 500 shares — an estimated $379 sold.

TCI Wealth Advisors first reported a position in VXRT in Q3 2020 and held it in 11 quarters. The position peaked at $7K in Q4 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 500 Vaxart shares in Q2 2023, an estimated $379.
  • TCI Wealth Advisors first reported a position in Vaxart in Q3 2020 and held it in 11 quarters.
  • TCI Wealth Advisors's Vaxart position peaked at $7K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.